DRKS00020912已完成不适用
HYDROmed BLUE drops in everyday life - AT-HBATIA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Dry eye due to external influences such as:
- •- heating air, air conditioning
- •- wind, cold or heat stimuli
- •- Eye fatigue from computer workstations, computer games, smartphones
- •reactions caused by taking medication that can lead to dry eyes,
- •- acetylsalicylic acid (for pain, to thin the blood)
- •- anticholinergics (for colic or chronic bronchitis)
- •- beta-blockers (for high blood pressure, irregular heartbeat, fast pulse)
- •- Ergotamine (for migraines)
- •- isotretinoin (for skin diseases such as acne)
- •- neuroleptics (for psychoses)
- •- estrogens (for menopause symptoms)
- •- reserpine (for arterial hypertension)
- •- thiazide diuretics (for increased blood pressure, edema)
- •- tri- and tetracyclic antidepressants (for depressive disorders, anxiety)
排除标准
- •eye inflammation (bacterial or viral)
- •Eye surgery (in the past 6 weeks)
- •all medications that could influence the course of the study (e.g. antihistamines)
- •Autoimmune diseases
- •Pregnancy and breast feeding period
- •Use of contact lenses during the study
- •Known intolerance of an ingredient in the HYDROmed BLUE drops
研究者
相似试验
尚未招募
3 期
Hydroxyurea – Pragmatic Reduction in Mortality and Economic burden: A multi-centre Phase III trial to investigate the efficacy of hydroxyurea for children with sickle cell anaemia when administered in a pragmatic fashion.Haematological DisordersPaediatricsBacterial infectionMalariaPACTR202401802272880Imperial College1,800
进行中（未招募）
3 期
H-PRIME: A clinical trial with three separate randomisations aimed at investigating the benefits of hydroxyurea, used pragmatically with only clinically-based monitoring, antimalarial prophylaxis with dihydroartemisinin-piperaquine and antibacterial prophylaxis with cotrimoxazole as potential improvements in the standard care of children living in Africa with sickle cell diseaseCirculatory SystemSickle cell diseaseISRCTN15724013Imperial College London1,800
已完成
不适用
Blood Volume Analysis and Related Outcomes in HemodialysisEnd Stage Kidney DiseaseNCT01679249VA New York Harbor Healthcare System10
已完成
不适用
The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary BypassBlood Coagulation DisordersNCT01435304MaineHealth100
已完成
不适用
Intradialytic Drug Removal by Short-daily HemodialysisEnd Stage Renal DiseaseInfectionNCT00596167Indiana University School of Medicine6